PATENT CLAIM ANALYSIS

Application Number: 16122015
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["514", "013500"]

Abstract:
Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficienty are disclosed.

Claim (Index 21):
The lyophilized pharmaceutical composition of  claim 20 , wherein the concentration of citrate in the solution is about 10 mM.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15837969', '15837677', '15837938', '15837693', '14855168']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6871872819331526
- 35 USC 102 Novelty (BERT): 0.5129776068795598
- Combined Prediction Score: 0.6697663144277933
- Mean Citation Score: 270.9834
- Max Citation Score: 275.21338
- Similarity Product: 215.39660318500992

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test